NYSE:MDTMedical Equipment
Is Medtronic’s (MDT) Pain-Portfolio Pivot Offsetting Quality Scrutiny From Its Pediatric Cannula Recall?
In May 2026, Medtronic initiated a voluntary Class II recall of specific lots of its DLP One-Piece Pediatric Arterial Cannula after reports of loose foreign material containing trace blood, with the action now ongoing and affecting worldwide distribution including several US states.
At the same time, Medtronic has been reshaping its portfolio with the US$650 million SPR Therapeutics acquisition and ViaVerte pain system launch, adding non-opioid therapies alongside near-term quality and...